Antipruritic effects of Sophora flavescens on acute and chronic itch-related responses in mice

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 5, 2003, Pages 722-724

  Yamaguchi Miyamoto, Tomomi ^a,b   Kawasuji, Toru ^b   Kuraishi, Yasushi ^c   Suzuki, Hideyo ^b  

^a JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^b Toyama Prefectural Institute for Pharmaceutical Research   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Atopic dermatitis; Herbal medicine; Itch; NC mice; Serotonin

Indexed keywords

ANTIPRURITIC AGENT; CNIDIUM MONNIERI EXTRACT; PLANT EXTRACT; SEROTONIN; SOPHORA FLAVESCENS EXTRACT; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; CHRONIC DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRURITUS; SOPHORA; SOPHORA FLAVESCENS; ANIMAL; ANIMAL BEHAVIOR; CHEMISTRY; COMPARATIVE STUDY; DISEASE MODEL; INSTITUTE FOR CANCER RESEARCH MOUSE; MOTOR ACTIVITY; ORAL DRUG ADMINISTRATION; PHYTOTHERAPY;

ACUTE DISEASE; ADMINISTRATION, ORAL; ANIMALS; ANTIPRURITICS; BEHAVIOR, ANIMAL; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; PHYTOTHERAPY; PLANT EXTRACTS; PRURITUS; SOPHORA;

EID: 1542439768     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.26.722     Document Type: Article

References (20)

1. Krause L., Shuster S., Br. Med J., 287, 1199-1200 (1983).
2. Savin J. A., Dow R, Harlow B. J., Massey H., Yee K. F., Clin Exp Dermatol., 11, 600-602 (1986).
3. Wahlgren C.-F., Acta. Derm. Venereol. Suppl. (Stockh), 165, 1-53 (1991).
4. Tohda C., Kakihara Y, Komatsu K., Kuraishi Y., Biol. Pharm. Bull., 23, 599-601 (2000).
5. Yamaguchi T., Nagasawa T., Satoh M., Kuraishi Y., Neurosci. Res., 35, 77-83 (1999).
6. Fjellner, B., Hägermark Ö., Acta Derm. Venereol. (Stockh), 59, 505-512 (1979).
7. Fitzsimons E J., Dagg J. H, McAllister E J., Br Med. J, 283, 277 (1981)
8. Schworer H., Hartmann H., Ramadori G., Pain, 61, 33-37 (1995)
9. Andoh T., Kuraishi Y., Eur. J. Pharmacol., 406, 149-152 (2000).
10. Matsuda H., Watanabe N., Geba G. P., Sperl J., Tsudzuki M., Hiroi J, Matsumoto M., Ushio H., Saito S., Askenase P. W., Ra C., Int. Immunol., 9, 461-466 (1997).
11. Tohda C., Yamaguchi T., Kuraishi Y., Neurosci. Res., 29, 209-215 (1997).
12. Yamaguchi T., Maekawa T., Nishikawa Y., Nojima H., Kaneko M., Kawakita T., Miyamoto T., Kuraishi Y., J. Dermatol. Sci., 25, 20-28 (2001).
13. Andoh T., Nagasawa T., Satoh M., Kuraishi Y., J Pharmacol Exp. Ther., 286, 1140-1145 (1998).
14. Andoh T., katsube N., Maruyama M, Kuraishi Y., J. Invest. Dermatol, 117, 1621-1626 (2001).
15. Inagaki N., Nakamura N., Nagao M, Musoh K., Kawasaki H., Nagai H., Eur. J. Pharmacol., 367, 361-371 (1999).
16. Cho C. H., Chuang C. Y., Chen C. F, Planta Med, 52, 343-345 (1986).
17. Yamazaki M., Arai A., Suzuki S., Takeuchi T., J. Pharm Soc Jpn., 104, 293-301 (1984).
18. Tan H., Zhang B., Chin. J. Integrat. Chin. West. Med, 5, 108-110 (1985).
19. Kojima R., Fukushima S., Ueno A., Saiki Y., Chem. Pharm Bull., 18, 2555-2563 (1970).
20. Kamei J., Xiao P., Ohsawa M., Kubo H., Higashiyama K., Takahashi H., Li J., Nagase H, Ohmiya S., Eur. J Pharmacol, 337, 223-226 (1997).